ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
GenSight Biologics S.A.

GenSight Biologics S.A. (SIGHT)

0.283
-0.003
(-1.05%)
Cerrado 19 Enero 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.283
Postura de Compra
0.28
Postura de Venta
0.291
Volume Operado de la Acción
175,843
0.281 Rango del Día 0.293
0.23 Rango de 52 semanas 0.598
Capitalización de Mercado [m]
Precio Anterior
0.286
Precio de Apertura
0.286
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
280,022
Acciones en circulación
78,370,724
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.84
Beneficio por acción (BPA)
-0.33
turnover
2.96M
Beneficio neto
-26.22M

Acerca de GenSight Biologics S.A.

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sede
Paris, Paris, Fra
Fundado
-
GenSight Biologics S.A. is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker SIGHT. The last closing price for GenSight Biologics was 0.29 €. Over the last year, GenSight Biologics shares have traded in a share price range of 0.23 € to 0.598 €.

GenSight Biologics currently has 78,370,724 shares in issue. The market capitalisation of GenSight Biologics is 22.41 € million. GenSight Biologics has a price to earnings ratio (PE ratio) of -0.84.

SIGHT Últimas noticias

GenSight Biologics announces a financing for an amount of c. €1.5 million from existing investors

THIS PRESS RELEASE IS NOT BEING MADE IN AND COPIES OF IT MAY NOT BE DISTRIBUTED OR SENT, DIRECTLY OR INDIRECTLY, INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA Regulatory News:...

GenSight Biologics announces a financing for an amount of c. €2.8 million from existing investors

Regulatory News: This press release is not being made in and copies of It may not be distributed or sent, directly or indirectly, into the United States, Canada, South Africa, Japan or...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News : GENSIGHT BIOLOGICS (Paris:SIGHT) : (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GenSight Biologics : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GenSight Biologics (Paris:SIGHT) (Code ISIN : FR0013183985): Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT): Date Nombre d’actions composant le capital Nombre de droits de vote brut1 Nombre de droits de...

GENSIGHT BIOLOGICS: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS  (Paris:SIGHT): (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.0020.7117437722420.2810.2980.2691880910.27965754DE
40.0176.390977443610.2660.2980.261578030.27698287DE
12-0.077-21.38888888890.360.37350.232800220.31076553DE
26-0.026-8.41423948220.3090.4960.233376770.35238347DE
52-0.167-37.11111111110.450.5980.232298880.36765289DE
156-4.987-94.62998102475.275.380.232087721.25102179DE
260-3.667-92.8354430383.959.690.232763553.18901462DE

SIGHT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de GenSight Biologics?
El precio actual de las acciones de GenSight Biologics es 0.283 €
¿Cuántas acciones de GenSight Biologics están en circulación?
GenSight Biologics tiene 78,370,724 acciones en circulación
¿Cuál es la capitalización de mercado de GenSight Biologics?
La capitalización de mercado de GenSight Biologics es EUR 22.41M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de GenSight Biologics?
GenSight Biologics ha negociado en un rango de 0.23 € a 0.598 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de GenSight Biologics?
El ratio precio/beneficio de GenSight Biologics es -0.84
¿Cuál es el ratio de efectivo a ventas de GenSight Biologics?
El ratio de efectivo a ventas de GenSight Biologics es 7.41
¿Cuál es la moneda de reporte de GenSight Biologics?
GenSight Biologics presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de GenSight Biologics?
El último ingresos anual de GenSight Biologics es EUR 2.96M
¿Cuál es el último beneficio anual de GenSight Biologics?
El último beneficio anual de GenSight Biologics es EUR -26.22M
¿Cuál es la dirección registrada de GenSight Biologics?
La dirección registrada de GenSight Biologics es 74, RUE DU FAUBOURG SAINT-ANTOINE, PARIS, PARIS, 75012
¿Cuál es la dirección del sitio web de GenSight Biologics?
La dirección del sitio web de GenSight Biologics es www.gensight-biologics.com
¿En qué sector industrial opera GenSight Biologics?
GenSight Biologics opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
DRVDSDrone Volt
0.0039 €
(3,800.00%)
774.48k
GTRDSGroupe Tera DS
0.0585 €
(800.00%)
3.27k
ALCYBCybergun
0.0002 €
(100.00%)
3.98M
DMSBSDiagnostic Medical Systems
0.0075 €
(87.50%)
129.59k
NICBSNicox SA
0.0265 €
(50.57%)
979
MLSMLSmalto
0.014 €
(-33.33%)
1.62k
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
MLIDSIds
0.364 €
(-19.11%)
1.12k
MCPGrupo Media Capital Sgps Sa
1.62 €
(-19.00%)
3
ALBOOBOOSTHEAT
0.063 €
(-15.78%)
70.91k
ATOAtos SE
0.002 €
(-4.76%)
2.53B
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
BCPBanco Comercial Portugues SA
0.4988 €
(0.79%)
69.25M
EDPEDP SA
3.149 €
(1.22%)
13.56M
VIVVivendi SE
2.546 €
(-1.01%)
8.93M
excel excel 4 minutos hace
Yep, Ravens beat themselves.
excel excel 4 minutos hace
Yep, I feel sorry for him. The one time and somehow drops it.
Can't believe the defense hadn't seen that play in prep?
Ravens done it many times.
Heck lot of teams do it if one gets proper angle it is nearly impossible to defend that play.
Yet they weren't even close t
HoldEm777 HoldEm777 5 minutos hace
I said long ago I thought it was going T8. But it’s held .001 two times. Maybe another small rally first…or a flush at open to wick down then rally. I guess I have gotten to deep in the weeds on the story and lost touch on the chart. This is where they usual get cloudy for me to predict… looks like
RDAR
Bubae Bubae 5 minutos hace
They may be getting ready to clear the 345 million restricted shares. They are suppose to divest all debts, other than the trade payables by December 31, 2024. This is a messy deal and it is not for certain that they moved all of the nearly 2.3 billion shares that they issued in October and November
RDAR
Zardiw Zardiw 6 minutos hace
I've always liked $TANH.................

Z
TANH
CanItBThisEZ2Make CanItBThisEZ2Make 7 minutos hace
18 REAL Products More Details Coming Soon!! ---->
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175683611

GO SRMX(TCCI)$
SRMX
Zardiw Zardiw 8 minutos hace
I guess TikTok is like one of those banks that's 'Too Big to Fail'................

Z
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 8 minutos hace
You will love $TANH, my good ole friend!

https://www.stockscores.com/chart.asp?TickerSymbol=tanh&TimeRange=60&Interval=60&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=None&Band=BB&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2=50&Indicator1=Non
TANH
Zardiw Zardiw 9 minutos hace
Worth $Billions: $TORVF New Patent:

They will have the ONLY legal way to process Graphite.

The current method uses HydroFlouric Acid, which is illegal, except for China.

And China has restricted Graphite shipments, and will be Tariffed to a Fare-thee-well
BILLIONS TORVF
Zardiw Zardiw 10 minutos hace
Worth $Billions: $TORVF New Patent:

They will have the ONLY legal way to process Graphite.

The current method uses HydroFlouric Acid, which is illegal, except for China.

And China has restricted Graphite shipments, and will be Tariffed to a Fare-thee-well
BILLIONS TORVF
bigstocksnbonds bigstocksnbonds 11 minutos hace
REALLY GREAT JOB!! A BUNCH!!
Zardiw Zardiw 12 minutos hace
Why I love $TORVF:

1. Their CEO is a mini version of Elon Musk

2. They have massive Graphite mining claims, which are up to 80% pure.

3. Their Air Qualifier for Graphite is a technological revolution in Graphite Production.

--- And it ha
TORVF
Admtiger Admtiger 12 minutos hace
I just ran across this stock and looked on OTC Markets. Seems like the last quarterly was in 2020. They are listed as Pink current. How can this be?
KPIFF
oldstocks oldstocks 12 minutos hace
Richie that stock you replied about
Was .000001-.0001-.0002 from August-October

The main point here is that company had a complete turnaround in stock price! Would it be great for AFFU to have a major event to turn around the share price of AFFU?? I think so!

AFFU
Zardiw Zardiw 12 minutos hace
Why I love $TORVF:

1. Their CEO is a mini version of Elon Musk

2. They have massive Graphite mining claims, which are up to 80% pure.

3. Their Air Qualifier for Graphite is a technological revolution in Graphite Production.

--- And it ha
TORVF
Zardiw Zardiw 12 minutos hace
Why I love $TORVF:

1. Their CEO is a mini version of Elon Musk

2. They have massive Graphite mining claims, which are up to 80% pure.

3. Their Air Qualifier for Graphite is a technological revolution in Graphite Production.

--- And it ha
TORVF
ducci1 ducci1 13 minutos hace
Pivot Calcs: SPX Pivot--5996----R1--6014----R2--6032----S1--5978----S2--5960-----SPY--597----R1--599----S1--595-----ES Pivot--6020-----Vix Pivot--15.91----R1--16.29----S1--15.60 !!LOL!!


SPY
rbtree rbtree 13 minutos hace
Pretty amazing. Sigh...
STAL
Zorax Zorax 14 minutos hace
Totally agree. But at this point, impeaching him or him just plain dying on the golf course may not stop the 2025 people or their agenda.
I believe their most important single point was to get full control of the WH and both chambers. From there they have all the levers. shitface was only th
Flobewan Flobewan 14 minutos hace
Well fine, how about this one, Goodbye Joe, you gotta go, me oh ni oh
Split T Split T 16 minutos hace
I CAUGHT YOU IN YOUR MASSIVE EXAGGERATION OF LOSING 2 BILLION DOLLARS ON
Bof A stock and others on this board know you like to exagergert ,but this is really over the
Top for you to tell someone to "go get a job, and stop posting cra*p on the message board"

I personall
COOP
Zorax Zorax 18 minutos hace
Seems to me the anti-vaxx movement has moved into the profitable stage as the main motivator and not health issues themselves. Much like bannon and kirk who spew total lies because they know that it creates clicks and ad money as well as incredibly stupid people donating. The anti-vax movement (or b
gfp927z gfp927z 19 minutos hace
The Donald sellout, what won't this guy do for a buck?

-- >>> Trump’s meme coin is his latest merchandise push in recent years, adding to a line of perfumes and colognes and “Trump Watches” celebrating his election win. He launched a series of “Trump Watches” valued up to $100,000 in

Su Consulta Reciente